<?xml version="1.0" encoding="UTF-8"?>
<ref id="B2-pharmaceutics-12-00388">
 <label>2.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Coughlan</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Sridhar</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Payne</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Edmans</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Milicic</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Venkatraman</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Lugonja</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Clifton</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Qi</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Folegatti</surname>
    <given-names>P.M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults</article-title>
  <source>EBioMedicine</source>
  <year>2018</year>
  <volume>29</volume>
  <fpage>146</fpage>
  <lpage>154</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ebiom.2018.02.011</pub-id>
  <?supplied-pmid 29519670?>
  <pub-id pub-id-type="pmid">29519670</pub-id>
 </element-citation>
</ref>
